KBR Inc $ 24.35 -0.32 (-1.3%)
KBR News and Headlines - KBR Inc
In order to come across value opportunities, investors may want to consider stocks whose earnings returns have outperformed that of the 20-year high-quality market corporate bonds.
These bonds represent corporate loans that have been issued by triple-A, double-A and single-A rated companies, which have a high capacity to repay their loans. As a result, the U.S.-listed equities that represent these issuers of investment-grade bonds imply a very low investment risk for their shareholders.
Thus, investors may want to have a look at the following stocks, as their earnings returns have recently more than doubled the monthly spot rate that the
KBR, Inc. (KBR - $30.50 - NYSE) (KBR) has transitioned from an engineering and construction (E&C) business to a government service business under new CEO, Stuart Bradie, which led to its recent reclassification from the Industrial to the Technology sector. KBR had a strong year in its Government Services segment securing more business than expected under the LOGCAP V military base contract. With the reclassification and Government Services a larger mix of the total company, the company has received a higher valuation versus the core E&C peers. In addition, the company was able to complete the work on the
To Our Shareholders:
For the quarter ended December 31, 2019, the KEELEY Small-Mid Cap Value Fund’s net asset value (“NAV”) per Class A share increased 9.64% versus a gain of 7.07% for the Russell 2500 Value Index. During the full-year 2019, the Fund gained 31.65% versus 23.57% for the Russell 2500 Value Index.
The old adage, “Don’t fight the Fed” remains true. With the Fed on hold given the dovish bias for 2020, plus the outlook for renewed growth in trade/capital spending as the uncertainty is lifted with Phase I of the China/US trade agreement, the market posted another
KBR, Inc. (KBR - $30.50 – NYSE) (KBR) operates two similar but unrelated businesses; Government Solutions which provides outsourcing services to government entities (mostly the US Government), and Energy Solutions which provides engineering, construction, and maintenance services to global energy and utility companies. Shares performed well during the fourth quarter due to solid third quarter results, strong bookings in both businesses, and continued progress in completing and resolving a troubled Energy Solutions project.
From Keeley Asset Management's Small Cap Dividend Value Fund fourth-quarter shareholder commentary.
To Our Shareholders:
For the quarter ended December 31, 2019, the KEELEY Small Cap Dividend Value Fund’s net asset value (“NAV”) per Class A share rose 5.55% versus an 8.49% gain for the Russell 2000 Value Index. During the full-year 2019, the Fund gained 22.36% compared with a 22.39% gain for the benchmark.
After limping into the end of 2018, the market bounced back in the first quarter and never looked back. As measured by the S&P 500 (or any other Index for that matter), the market rose in all four quarters, historically the market has had this outcome
According to the GuruFocus All-in-One Screener, the following companies with market caps over $5 billion look cheap since they are trading with low price-sales ratios.
SRC Energy Inc. (SRCI) shares are trading around $5.24 with a price-sales ratio of 2.26 and a price-earnings ratio of 5.46. The company which operates in the exploration and production of oil and natural gas properties, has a market cap of $1.27 billion. The stock has risen at an annualized rate of 6.6% over the last 10 years.
The discounted cash flow calculator gives the
Recent correction in oil prices have taken a toll on Chicago
In this article, let's take a look at Fluor Corporation (FLR), a $9.31 billion market cap company, which is one of the world's largest engineering, procurement and construction companies, with more than 65% of its backlog derived from outside the U.S.
The company operates in different segments: Oil and Gas 42% of 2013 revenues, Industrial and Infrastructure, 41%; Global Services, 2%; Government, 10% and Power, 5%. Obviously, more than 80% is concentrated in the O&G and I&I businesses, the other three business segments should become more important in the future. For example, new gas-fired plants or alternative energy
According to GuruFocus list of 3-year lows, Talisman Energy Inc, KBR Inc, Quality Systems Inc, and Arch Coal Inc. have all reached their 3-year lows.
Talisman Energy Inc (TLM) Reached $9.69
The prices of Talisman Energy Inc (TLM) shares have declined to $9.69, which is 38.5% off the 3-year high of $15.39.
Talisman Energy Inc, is incorporated under the Canada Business Corporations Act. Talisman Energy Inc has a market cap of $9.91 billion; its shares were traded at around $9.69 with and P/S ratio of 2.15. The dividend yield of Talisman Energy Inc stocks is 2.82%.
Talisman Energy Inc.
About the Business
KBR Inc. was incorporated in Delaware as an indirect wholly-owned subsidiary of Halliburton Company. The company is a global engineering, construction and services company supporting the energy, hydrocarbon, government services, minerals, civil infrastructure, power and industrial sectors. KBR offers a range of services through six business units: Government and Infrastructure, Upstream, Services, Downstream and Technology and ventures.
KBE has seen declining revenues over the past five years (five-year revenue trend of -11.5%); however, amid falling revenues, gross margin has increased. KBR is making a larger percentage of gross profit from its revenues despite seeing falling revenues.
This morning we will take a look some of the most widely held guru stocks that are near their 52-week lows.
Coca-Cola (KO) closed at $38.33 on Wednesday near its 52-week low of $36.83. The company manufactures, markets and sells nonalcoholic beverages worldwide. It is held by 27 gurus we follow.
Market Cap: $168.88 billion, P/E: 20.30
Business Predictability: 5/5, Financial Strength: 7/10, Profitability & Growth: 8/10
Zoetis (ZTS) closed at $29.62 on Wednesday near its 52-week low of $28.66. The company engages in the discovery, development, manufacturing and commercialization of animal health medicines